Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED December 31, 2022 or ☐ TRANSMISSION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 001-35518 SUPERNUS PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) Delaware 20-2590184 (State or o ...

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q4 2022 Earnings Conference Call February 28, 2023 4:30 PM ET Company Participants Peter Vozzo - ICR Westwicke, IR Jack Khattar - CEO Tim Dec - CFO Conference Call Participants David Amsellem - Piper Sandler Andrew Tsai - Jefferies Jack Padovano - Stifel Operator Good afternoon, and welcome to Supernus Pharmaceuticals Fourth Quarter and Full Year 2022 Financial Results Conference Call. At this time all participants are in a listen-only mode. Later we will conduct ...

| --- | --- | |------------------------------------------------------------|-------| | | | | Supernus Pharmaceuticals | | | Corporate Overview September 2022 | | | © 2022 Supernus Pharmaceuticals, Inc. All Rights Reserved. | | 1 Safe Harbor Statement This presentation and other matters discussed today or answers that may be given to questions asked include forward-looking statements within the meaning of the federal securities laws. These statements, among other things, relate to Supernus' business strategy ...

Clara, person with Parkinson's and origami hobbyist Making everyday life significantly better for people affected by neurological diseases May, 10 2021 © 2021 Adamas Pharmaceuticals, Inc. | All Rights Reserved. Confidential and Proprietary. Forward looking statements 2 › Statements contained in this presentation regarding matters that may occur in the future are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements c ...

Clara, person with Parkinson's and origami hobbyist Making everyday life significantly better for people affected by neurological diseases May, 10 2021 © 2021 Adamas Pharmaceuticals, Inc. | All Rights Reserved. Confidential and Proprietary. Forward looking statements 2 › Statements contained in this presentation regarding matters that may occur in the future are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements c ...

| --- | --- | |------------------------------------------------------------------------------------------|-------| | | | | | | | Supernus Pharmaceuticals | | | © 2021 Supernus Pharmaceuticals, Inc. All Rights Reserved. Corporate Overview April 2021 | | Safe Harbor Statement This presentation and other matters discussed today or answers that may be given to questions asked include forward-looking statements within the meaning of the federal securities laws. These statements, among other things, relate to Sup ...

Clara, person with Parkinson's and origami hobbyist Making everyday life significantly better for people affected by neurological diseases MARCH 2, 2021 © 2021 Adamas Pharmaceuticals, Inc. | All Rights Reserved. Confidential and Proprietary. Forward looking statements 2 › Statements contained in this presentation regarding matters that may occur in the future are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements ...

| --- | --- | |------------------------------------------------------------|-------| | | | | | | | Supernus Pharmaceuticals Corporate Overview February 2021 | | | © 2021 Supernus Pharmaceuticals, Inc. All Rights Reserved. | | Safe Harbor Statement This presentation and other matters discussed today or answers that may be given to questions asked include forward-looking statements within the meaning of the federal securities laws. These statements, among other things, relate to Supernus' business strategy, g ...

Clara, person with Parkinson's and origami hobbyist Making everyday life significantly better for people affected by neurological diseases FEBRUARY 23, 2021 © 2021 Adamas Pharmaceuticals, Inc. | All Rights Reserved. Confidential and Proprietary. Forward looking statements › Statements contained in this presentation regarding matters that may occur in the future are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including but not limited to, statement ...

| --- | --- | |------------------------------------------------------------------------------------------------|-------| | | | | | | | Supernus Pharmaceuticals | | | © 2021 Supernus Pharmaceuticals, Inc. All Rights Reserved. Overview Presentation January 2021 | | Safe Harbor Statement This presentation and other matters discussed today or answers that may be given to questions asked include forward-looking statements within the meaning of the federal securities laws. These statements, among other things, re ...